In a multi-institutional study published today in Nature Nanotechnology, researchers from The University of Texas MD Anderson ...
Known online as Szymool, Szymon Besser is a professional gambler, influencer, entrepreneur, brand founder and successful live-streamer.
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
While artificial intelligence (AI) models have proved useful in some areas of science, like predicting 3D protein structures, ...
The medical consequences of traumatic brain injuries are well-studied and affect millions of Americans every year. But one of ...
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...
NORFOLK, Va. — A new pneumatic tube system at Sentara Leigh Hospital in Norfolk is reshaping how medical specimens and ...
AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to ...
Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...
Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...
The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...
2025 saw many advancements in many fields, from medicine and genetics, to environmental science or artificial intelligence.